Clinical Trial

Safe-Age Study: A Safety and Tolerability Study of a Nutritional Supplement in Healthy Older Adults

Study acronym: SAFE-AGE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 2, 2026 (before its estimated July 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the safety and tolerability of the nutritional supplement Youniqor in healthy older adults. The main questions it aims to answer are: Is Youniqor safe and well tolerated when taken daily by healthy adults aged 60 to 80 years? Are there any adverse events or clinically relevant changes in vital signs or laboratory parameters during the study period? Participants will: Take Youniqor daily for 8 weeks Attend scheduled study visits for safety assessments, including vital signs, blood and urine tests, and electrocardiograms Report any adverse events during the study period
Trial Details
NCT Number NCT07442097
Lead Sponsor YOXLO B.V.
Collaborators: Vedic Lifesciences Pvt. Ltd.
Conditions Aging, Healthy
Enrollment 16 participants
Start Date 2026-02-12
Primary Completion 2026-07-10 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-02